TG
IONS icon

TLP Group’s Ionis Pharmaceuticals IONS Stock Holding History

TLP Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,522
Closed -$199K – 436
2018
Q1 		$199K Buy
4,522
+4,437
+5,220% +$225K 0.14% 271
2017
Q4 		$4K Sell
85
-5,190
-98% -$285K ﹤0.01% 466
2017
Q3 		$267K Buy
5,275
+5,220
+9,491% +$273K 0.17% 168
2017
Q2 		$3K Buy
+55
New +$2.56K ﹤0.01% 283

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

TLP Group's IONS Position: Q2 2018 in Review

TLP Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2018, closing a stake of 4,522 shares — an estimated $199K sold.

TLP Group first reported a position in IONS in Q2 2017 and held it in 4 quarters. The position peaked at $267K in Q3 2017. 307 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

  • TLP Group reported no remaining Ionis Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • TLP Group sold 4,522 Ionis Pharmaceuticals shares in Q2 2018, an estimated $199K.
  • TLP Group first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • TLP Group's Ionis Pharmaceuticals position peaked at $267K in Q3 2017.
  • 307 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.